Healio

FDA efforts to reduce animal testing signal shift toward AI, organ-on-chip study methods

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

Chlorine Dioxide Gas Residual Testing Peer-Reviewed Study Published

Clordisys, headquartered in Branchburg, New Jersey, announces the publication of Chlorine Dioxide Medical Device Sterilization: Residual Toxicity Testing in the Journal of Medical and Biological ...

Human intestinal cell model enables precise detection of drug-induced barrier damage

Researchers have developed a human intestinal cell model that closely mimics the structure and function of the human gut, enabling more precise prediction of drug-induced gastrointestinal toxicity ...
Targeted Oncology

ctDNA Test Improves Early Detection of Immunotherapy Response in Cancer

A genome-wide cfDNA methylation enrichment method (cfMeDIP-seq) enables response monitoring using plasma alone, avoiding ...
The Manila Times

VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales

Veteran business development leader with deep expertise in human-relevant NAM and spheroid-based in vitro services to spearhead commercial growth along the US East Coast, deepening VivoSim’s reach wit ...